Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice. As always, please remember that I am an amateur investor, so please consult with your professional investment advisors prior to making any investment decisions based on information on this website.
One thing I try very hard around here to accomplish is to share with you actual trades in my very real "Trading Portfolio". I choose from the stocks that I have discussed and use the same rules to pick these holdings as I do when I review stocks on this blog.
As I have pointed out elsewhere, I have some very disciplined trading rules that I have established for my holdings. First of all I have selling rules on the downside. Let me review if you are not familiar: all stocks subject to sale at an 8% loss after first purchase. If I have sold a portion of a stock once at a 30% gain target, then I sell the remaining shares if the stock retraces back to "break-even". Otherwise, I sell all of the other stocks at 50% of their highest targeted gain-sale point. That is if I sold a portion at 60% gain, then I would allow it to retrace to a 30% gain level before unloading the issue.
On the upside, I sell 1/4 of my position at 30, 60, 90, 120% points, then increase by 60%: 180, 240, 300, and 360% target, then increase by 90%: 450%,....etc.
Going back to the subject at hand, I acquired my shares of St. Jude Medical (STJ) on 10/15/03 at a cost basis of $28.90/share. I made my first sale on 1/28/04, selling 30 shares at $69.84 (out of an original holding of 150 shares). The stock subsequently split, and with 240 shares, I have now hit a 60% gain level (my second targeted sale point), and have just a few moments ago sold 60 shares at $46.72, with a gain of $17.82/share or a 61.7% gain. Thus, my next sale will be at a target of either 90% on the upside or 30% gain on the downside.
What drove the stock higher today was an announcement just prior to the opening of 2nd quarter 2005 results which beat the street by $.02. In addition, guidance was raised for the 3rd quarter of 2005. Sales for the quarter ended June 30, 2005 came in at $724 million, a 30% increase over the prior year's same quarter. Net earnings for the quarter excluding non-recurring items (including them the result was flat at $.27), came in at $.38/diluted share, a 41% increase over the $.27/share reported the prior year.
Anyhow, things look solid for STJ and the stock as I write this note is trading at $46.70, up $2.95 or 6.74% on the day!
Regarding my own portfolio management, since I am up to 25 positions, I will not be adding a new position as a sale at a gain allows, and instead shall continue to work on paying down my sizeable margin level. Otherwise, if I sell one of my 25 on bad news, then that would open up a slot and a future sale at a gain would once again allow me to add positions up to my goal of 25.
Thanks again for stopping by! If you have any questions, comments, or words of encouragement, please feel free to email me at firstname.lastname@example.org. Please be aware that I shall probably use your question in the blog itself! Regards to all.